← Eichor
Study identifier: NCT06213012 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Harnessing Neuroplasticity of Postural Sensorimotor Networks Using Non-Invasive Spinal Neuromodulation to Maximize Functional Recovery After Spinal Cord Injury

Condition: Spinal Cord Injuries · Neuromodulation  ·  Sponsor: The Methodist Hospital Research Institute

PhaseNA
Planned participants60
Who can joinAll sexes, 22 Years to 75 Years
Healthy volunteersNo

About this study

It has been demonstrated that the human lumbosacral spinal cord can be neuromodulated with epidural (ESS) and transcutaneous (TSS) spinal cord stimulation to enable recovery of standing and volitional control of the lower limbs after complete motor paralysis due to spinal cord injury (SCI). The work proposed herein will examine and identify distinct electrophysiological mechanisms underlying transcutaneous spinal stimulation (TSS) and epidural spinal stimulation (ESS) to define how these approaches determine the ability to maintain self-assisted standing after SCI.

This description comes directly from the study's public registry record.

Talk to the study team

Jenny Dinh, BS  ·  585-507-1706  ·  jtdinh@houstonmethodist.org

Amanda Howes-Keith, MS  ·  585-507-1706  ·  achowes-keith@houstonmethodist.org

Always discuss trial participation with your own doctor first.

Locations (1)

Houston Methodist HospitalHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06213012